Evidence map›Paper›PMID 38384520›Full record

ArticleHeliyon2024

Time series traffic collision analysis of London hotspots: Patterns, predictions and prevention strategies.

Mohammad Balawi, Goktug Tenekeci

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 12 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mohammad BalawiCyprus International University, North Nicosia, North Cyprus.
Goktug TenekeciJacobs; and Cyprus International University, North Nicosia, North Cyprus.
Cyprus International University · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite recent measures on accident prevention, road collisions, mainly on London's "A" roads, persist as accident sources, endangering vulnerable users in particular. Analysing evidence from London's A-Roads unveils issues concerns and trends. This study utilises extensive data to target factors magnifying accidents: speed, traffic, vulnerable interactions. Stats 19 and transport data including volumes, types, speeds, and congestion parameters are all analysed alongside the collision data. The descriptive statistics have been employed to understand nature of data in the first instance. This has supported the process to cleanse the data outliers or periods where were subjected to incidents and interventions. Predictive model development is conducted to analyse and forecast accident frequency using ARIMA and SARIMAX models forecasted accident rates and interventions. ARIMA yielded higher accuracy. Method of analysis resulted in a statistically reliable formulation of the main factors, enabling use of this method for similar cities across the world. Formulated analysis revealed key contributors as population density, weather, and time of the day. The analysis of data supported identification of strategies emerging as infrastructure improvements, traffic control measures and severity and vulnerable users affected in particular. The analysis reveals distinct exhibits of causation, leading to focused recommendations on infrastructure enhancements, traffic control measures, and the impact on severity and vulnerable users, deviating from prior research findings. Insights aid safer London roads, have global predictive and mitigation value.

Indexed as

Accident frequency forecastingARIMA modelSafety measuresSARIMAX modelTime series analysisTraffic accidentsTraffic collisions

Identifiers

PMID38384520
PMCPMC10878868
OpenAlexW4391721012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.